Uterus Transplantation: Acceptability of the Procedure in Eligible Patients

Overview

This study aims to define the knowledge and acceptability of uterine transplantation in patients suffering from infertility due to congenital or acquired absence of this organ, which are followed up in the U.O.C. of Gynecology and Pathophysiology of Human Reproduction Polyclinic S. Orsola-Malpighi and registered with the Italian Association for Androgen Insensitivity and Similar Conditions-AISIA.

Absolute infertility from uterine factor (AUFI) is the term used to indicate the condition of women who cannot achieve pregnancy due to congenital or acquired absence of the uterus or the presence of an anatomically or physiologically non-functional utery1. The causes of AUFI can be classified in primary/congenital (Mayer-Rokitansky-Kuster-Hauser-MRKH syndrome, Complete insensitivity to androgens-CAIS) and secondary/acquired (Asherman syndrome, previous hysterectomy for benign/malignant gynecological pathologies). This condition was considered without therapeutic options until a few years ago, when the first birth from living donor uterus transplant was obtained (Sweden, 2014)2. There are many challenges to the transplantation of the uterus: * Ethical, complex and evolving issues: first of all the acceptability by patients;3 * the definition of inclusion criteria for donors and recipients, based on the results of procedures carried out to date;4 * the presence of the donor: deceased or living, and in the latter the use of minimally invasive surgical techniques5. Primary objective of the study Define the acceptability of the uterus transplant procedure in the target population through a cross-sectional observational study using a targeted questionnaire. Secondary objective To assess the knowledge of certain aspects of uterine transplantation among the population affected by SVCD. To identify the opinion and needs of the study population. Expected results The information will help improve the efficiency and quality of health services for people with SVD.

Conditions

Eligibility

Locations (1)

Outcomes